A Polymer Prodrug Strategy to Switch from Intravenous to Subcutaneous Cancer Therapy for Irritant/Vesicant Drugs.
Bordat A, Boissenot T, Ibrahim N, Ferrere M, Levêque M, Potiron L, Denis S, Garcia-Argote S, Carvalho O, Abadie J, Cailleau C, Pieters G, Tsapis N, Nicolas J.
Bordat A, et al.
J Am Chem Soc. 2022 Oct 19;144(41):18844-18860. doi: 10.1021/jacs.2c04944. Epub 2022 Oct 4.
J Am Chem Soc. 2022.
PMID: 36193551
Free PMC article.